How long do weight loss injections take to work?

The biggest myth: if nothing dramatic happens in week one, it isn't working

This is the misconception that sends people to online forums convinced their pen is faulty or their dose is wrong. The truth is straightforward: the opening dose of a weight loss injection is not a therapeutic dose. For tirzepatide (Mounjaro), treatment begins at 2.5 mg, a strength chosen because it gives your digestive system time to adjust, not because it is the dose that drives significant weight loss. The same logic applies to semaglutide (Wegovy), which opens at 0.25 mg weekly.

What you may feel in week one is a quietening of appetite and, for some people, mild nausea or digestive discomfort. That is the medicine doing something, but the scale may barely move, and that is completely expected. The mechanism behind weight loss injections involves slowing gastric emptying and acting on the brain's appetite centres, effects that compound gradually as doses climb.

Patience in the early weeks is not passive waiting. It is the foundation that makes higher doses tolerable later, and those higher doses are where the evidence-backed results live. Abandoning treatment after a fortnight because "nothing happened" is one of the most common reasons people miss the window where these medicines genuinely deliver.

The realistic timeline: what clinical trial data shows

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults on tirzepatide for 72 weeks. Average weight reduction at the 15 mg dose reached around 20–21%. That figure did not arrive in month one, it accumulated across the full trial period as participants moved through the titration schedule.

Semaglutide's STEP 1 trial (also 68 weeks, also published in the NEJM) reported roughly 15% average weight reduction at the 2.4 mg maintenance dose. Again, a result built over more than a year of treatment.

A practical way to think about it: most people reach their first maintenance dose somewhere between weeks 8 and 20, depending on how they tolerate each step. Visible progress on the scale typically follows the dose upward. Some notice a modest drop in the first month; others see little change until the dose climbs past the midpoint. Both patterns appear in trial data. If you want to explore the options available for weight loss injections, the clinical profile of each medicine matters as much as the headline figure.

The NHS tirzepatide patient page notes that treatment is intended to be used alongside a reduced-calorie diet and increased activity, a reminder that what happens between injections shapes how quickly the numbers move.

Factors that influence how quickly you see results

Two people on identical doses can have very different three-month check-ins. Starting weight plays a role: those with a higher BMI often lose more in absolute terms early on, though percentage loss tends to even out. Metabolic health, previous dieting history, sleep quality, stress hormones and gut microbiome composition all contribute, none of which are simple to control.

Diet quality matters considerably. The appetite suppression these medicines cause is a tool, not a substitute for adequate protein and fibre. Patients who use the reduced appetite to restructure their eating (rather than simply eating less of the same things) tend to report steadier progress. Your prescriber and, where available, a dietitian are the right people to guide that adjustment; it is not something a content page can personalise for you.

Adherence to the injection schedule is another variable. Missing doses or taking them irregularly disrupts the steady plasma level the medicine needs to work. A pharmacist's insight worth sharing: the question our prescribers hear most often from people who feel "stuck" is whether they skipped a dose the previous week.

If you are curious about how long you can stay on weight loss injections, that is a separate clinical question your prescriber will assess at each review, but most people need to think in terms of months, not weeks, before drawing conclusions about whether treatment is working.

When to raise concerns, and how nume supports you through the process

Slow early progress is normal. A total absence of any effect on appetite after several weeks at an established dose, or side effects that are not settling, are worth discussing with your prescriber. The length of time you take these injections should always be reviewed clinically, not decided in isolation.

If you experience severe, persistent stomach pain that radiates to the back, stop the injection and seek urgent medical help. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, infrequent but serious side effect of GLP-1 medicines. Nausea, loose stools and mild digestive discomfort are common and usually settle as your body adjusts, these alone are not a reason to stop, but they are worth logging and mentioning at your next clinical review.

You can report suspected side effects at Yellow Card, the MHRA's reporting service. At nume, every repeat order is reviewed by a GPhC-registered prescriber before dispatch, a real clinician reads your progress notes each time, not an automated system. If something is not going as expected, that review is the moment to flag it. You can also reach our clinical team through our support page seven days a week.

Thinking about cost alongside the timeline? A clear breakdown of what is included in private treatment is on our weight loss injections pricing page. When you feel ready to take the first step, start your free consultation and a prescriber will review your answers the same day.